Global Biomarker Research Services Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
“Global Biomarker Research Services Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global biomarker research services market report has been segmented on the basis of service type, therapeutic area, and region.
Global Biomarker Research Services Market: Overview
Biomarkers are cellular events used to link a specific environmental contact to a health outcome or target disease. Biomarkers play an important role in understanding the development of chronic human diseases and identification of subgroups that increases risk for disease. Biomarkers are extensively used in all therapeutic areas of medicine to diagnose a particular disease. In addition, biomarkers are used for drug approval process as included in regulatory submission processes. Biomarker research services are provided for development and validation of new biomarkers. These services are provided for different purposes such as biomarker validation & discovery of a biomarker, research assay, qualification, optimization, verification, and companion diagnostics.
Global Biomarker Research Services Market: Dynamics
Increasing incidences of diseases such as cancer, cardiovascular diseases, and neurological diseases and rising demand for biomarkers in diagnostic therapeutic across the globe is a key factor expected to drive growth of the global market over the forecast period.
In addition, increasing therapeutic areas of companion diagnostics in personalized medicine is another factor expected to further fuel growth of the target market over the forecast period.
Moreover, the investment in research and development activities in order to develop innovative product launches by key players operating in the target market is another factor expected to propel growth of the target market over the forecast period.
Furthermore, technological advancements in biomarker research services are expected to support growth of the target market over the forecast period.
However, high research cost for new drug development and inability to conduct biomarker research by pharmaceutical & biotechnology companies are major factors expected to restrain growth of the global market over the forecast period.
Merger & acquisition, collaboration, strategic partnerships, and new product launches are major business strategies adopted by major key players operating in the target market in order to improve their business.
Innovative product launches along with technological advancements are expected to create potential revenue opportunities for players operating in the target market over the forecast period.
Global Biomarker Research Services Market: Segment Analysis
Among the service type segments, the biomarker research services segment is expected to register significant growth in terms of revenue over the forecast period, owing to rising demand for biomarkers in diagnosis of various disease.
Among the therapeutic area segments, the cardiovascular diseases segment is expected to register significant growth over the forecast period.
Global Biomarker Research Services Market: Regional Analysis
The market in North America is expected to dominate into the global market and is expected to continue its dominance over the forecast period. This can be attributed to rising demand of biomarkers for disease diagnosis, increasing incidence of chronic diseases, companion diagnostic research for new drug development, increasing investment for R&D by kay players, etc. across various countries in this region.
Global Biomarker Research Services Market Segmentation:
Segmentation by service type:
- Biomarker Research Services
- Companion Diagnostic Research Services
Segmentation by therapeutic area:
- Cardiovascular Diseases
- Neurological Disorders
- Immunological Diseases
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Noble Life Sciences, Inc.
- ReproCELL USA Inc.
- Covance, Inc.
- PointCross Life Sciences
- Coriell Institute
- SRI International, Inc.
- ICON Public Limited Company
- Nordic Bioscience Holding A/S
- Proteome Sciences plc
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!